79.0%
co-stimulatory molecule agonist antibodiesinterleukin-2melanomasolid tumorsnon-melanoma epithelial neoplasms
…mbinations of other immunotherapies such as application of ICB, co-stimulatory molecule agonist antibodies, autophagy inhibition, and dendritic cell support strategies co…